Felix E. de Jongh

Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study

Gϋnter von Minckwitz, Andreas du Bois, Marcus Schmidt et al. · Journal of Clinical Oncology · 2009 · 689 citations

Medicine, Oncology, Pharmacotherapy +17

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

Lieke H. J. Simkens, Harm van Tinteren, Anne M. May et al. · The Lancet · 2015 · 528 citations

Medicine, Oncology, Pharmacology +13

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

Felix E. de Jongh, Harry L.A. Janssen, Robert A. de Man et al. · Gastroenterology · 1992 · 424 citations · Full text

Medicine, Pathology, Hepatology +11

Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients

Felix E. de Jongh, Ruben N. van Veen, S J Veltman et al. · British Journal of Cancer · 2003 · 267 citations · Full text

Medicine, Oncology, Pharmacology +17

mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients

Anieta M. Sieuwerts, Bianca Mostert, Joan Bolt‐de Vries et al. · Clinical Cancer Research · 2011 · 220 citations

Medicine, Cancer Biology, Oncology +17